Jeantet advises the China Medical System Group in connection with the acquisition of a participating interest in Eye Tech Care
Paris, 15 September 2022 – Jeantet has advised the Chinese group China Medical System in the context of (i) the acquisition of a participating interest, through certain subsidiaries of the group, of around 33.4% of the share capital of the French company Eye Tech Care and (ii) the signature of a license, collaboration and distribution agreement relating to the ultrasound glaucoma treatment device EyeOP1®.
Based in Shenzhen, the China Medical System group is a leader in the development and distribution of new medical treatments, particularly in the fields of dermatology and ophthalmology. This transaction aims to provide a new high-quality treatment option for glaucoma patients in China and Southeast Asian countries.
Founded in 2008 in Lyon by experts in therapeutic ultrasound and in partnership with INSERM, Eye Tech Care focuses on the application of therapeutic ultrasound technology in the fight against glaucoma, developing and promoting the EyeOP1® glaucoma treatment device for non-invasive UCP® treatment of this ophthalmological disease.
The Jeantet team was composed of Thierry Brun, (Partner), Maxime Brotz (Counsel), Pak-Hang Li, You Shang and Maria Plakci (Associates), for the Corporate/M&A aspects.
Eye Tech Care was advised by CMS Francis Lefebvre Avocats with Xinyu Hu and David Mantienne (Counsels), Yanchao Wu (Associate), for the Corporate/M&A aspects, Johann Roc’h and Henri Bitar (Partners) for the tax aspects, Nicolas Zhu (Partner – CMS Shanghai), and Laila Lu (Associate – CMS Shanghai), for the contract law aspects.
Jeantet strengthens its Corporate/M&A Department with the addiction of Quentin Mette as Counsel
Paris, 27 September 2022 – Quentin Mette, 36, joins Jeantet as Counsel to strengthen the corporate M&A department. éègraduated from the DJCE in Bordeaux with a double degree in business law and from Kedge Grande Ecole in corporate finance. Quentin started his professional career in 2011 as a lecturer at the University Montesquieu Bordeaux 4, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises the China Medical System Group in connection with the acquisition of a participating interest in Eye Tech Care
Paris, 15 September 2022 – Jeantet has advised the Chinese group China Medical System in the context of (i) the acquisition of a participating interest, through certain subsidiaries of the group, of around 33.4% of the share capital of the French company Eye Tech Care and (ii) the signature of a license, collaboration and distribution […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises Pitch Immo on the acquisition of Groupe XF
Paris, August 2, 2022, Jeantet has advised Pitch Immo, a brand of the Altarea Group, on the acquisition of Groupe XF. Based in Toulouse, Groupe XF is a developer and planner specialising in new real estate in Occitania. As part of Pitch Immo’s growth plan in regional cities, this operation will enable it to offer […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | REAL ESTATE | PUBLIC LAW – PUBLIC CONTRACTS
Jeantet advises the Emosia group on the acquisition of My Jolie Candle
Paris, July 28, 2022, Jeantet has advised the Emosia group, owner of Maison Berger Paris, on the acquisition of the My Jolie Candle start-up Emosia, the owner of Maison Berger Paris, Bougies la Française, and Ambiances Devineau, stands out as an emblematic brand and a leader in the market of home fragrances. My Jolie Candle, […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises ØRSTED on the acquisition of german wind turbine developer and operator OSTWIND
Paris, July 25, 2022, Jeantet has advised the Danish group Ørsted on the acquisition of the French business and portfolio of the German group Ostwind, developer, owner and operator of wind and photovoltaic farms, for an enterprise value of €689 million. With the acquisition of Ostwind, Ørsted enters the German and French markets and expands […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | ENERGY | REAL ESTATE | FINANCING | BANK-FINANCE-REGULATORY
Jeantet advises Apollo on its €500 million investment in Air France-KLM
Paris, July 19, 2022, Jeantet advises Apollo Global Management on the signing of a final agreement for a €500 million investment in a subsidiary of Air France-KLM. Apollo Global Management and Air France-KLM announced that they have entered into a final agreement relating to the issuance of perpetual super-subordinated notes, fully subscribed by Apollo Global […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | BANK-FINANCE-REGULATORY | TAX | RESTRUCTURING – LAW OF COMPANIES IN DIFFICULTY
Jeantet supports Sport Bridges Venture (SBV) in its entry into the capital of Paris FC
Paris, July 15, 2022, Jeantet supports Sport Bridges Venture (SBV), a consortium of French and American investors, in its acquisition of a minority stake in Paris FC. SBV becomes the fourth foreign investor in Paris FC, after the Kingdom of Bahrain in 2020, BRI Sports Holding in 2021 and Noah Football Group at the beginning […]
| CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises ABN AMRO Ventures in the context of the EUR 12.5M fundraising of DFNS.co
Paris, July 6, 2022 – Jeantet has advised ABN AMRO Ventures in the context of the EUR 12.5M fundraising of DFNS.co. DFNS.co, a French crypto-wallet start-up backed by Techstars and listed among the Future 40 start-up companies by the Station F, has raised EUR 12.5M to develop a secured crypto-custody protocol to secure digital assets. […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises german automotive and industry supplier Schaeffler in setting up a joint venture with Symbio, a Faurecia and Michelin Hydrogen Compagny
On 9 June 2022. Symbio, a Faurecia and Michelin hydrogen company, and Schaeffler Group, signed an agreement to establish Innoplate, a global 50:50 joint venture (JV) to produce fuel cell bipolar plates (BPP), a strategic fuel cell component. The JV and first plant are to be located in Haguenau (Alsace region), France, with the JV […]
Franco-German team, Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised Silverfleet Capital on the sale of the CoreDux Group to Arcline Investment Management
Paris, on 8 June 2022 – Jeantet advised Silverfleet Capital on the sale of the CoreDux Group, a manufacturer of flexible gas and fluid artery systems with group companies in the Netherlands, France, Germany and the United States, to Arcline Investment Management. Silverfleet Capital was advised by a joint team of Jeantet and the Dutch […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | REAL ESTATE | EMPLOYMENT
Jeantet advises Agrofert on the acquisition of Borealis’ nitrogen production business.
Paris, June 7, 2022 – Jeantet and the Austrian law firm Wolf Theiss have advised the Agrofert group, a European leader in the production of nitrogen fertilizers, on the acquisition of Borealis’ nitrogen production business, which includes fertilizers, melamine and technical nitrogen. The offer values Borealis’ “nitrogen” business on an enterprise value basis of EUR […]
Paris, Franco-German team | CORPORATE – M&A – PRIVATE EQUITY | EMPLOYMENT | BANK-FINANCE-REGULATORY | IP, TECH & DATA | REAL ESTATE | COMPETITION AND ECONOMIC LAW | PUBLIC LAW – PUBLIC CONTRACTS
Jeantet advises The Surgical Compagny Group (TSC GROUP) in connection with the sale of its distribution business in France and Benelux to Duomed Group
Paris, June 2, 2022 – Jeantet advised TSC Group, a leading manufacturer and distributor of specialized medical equipment and devices, in connection with the sale of its distribution business in France and Benelux to Duomed Group, a pan-European distributor of medical supplies. The TSC Group, which also includes the Medtech OEM business (via TSC PTM […]
Paris, Franco-German team | CORPORATE – M&A – PRIVATE EQUITY | TAX | EMPLOYMENT | BANK-FINANCE-REGULATORY | IP, TECH & DATA | REAL ESTATE | COMPETITION AND ECONOMIC LAW | PUBLIC LAW – PUBLIC CONTRACTS